John M. Davis

53.7k total citations · 16 hit papers
626 papers, 37.2k citations indexed

About

John M. Davis is a scholar working on Psychiatry and Mental health, Pharmacology and Molecular Biology. According to data from OpenAlex, John M. Davis has authored 626 papers receiving a total of 37.2k indexed citations (citations by other indexed papers that have themselves been cited), including 237 papers in Psychiatry and Mental health, 79 papers in Pharmacology and 77 papers in Molecular Biology. Recurrent topics in John M. Davis's work include Schizophrenia research and treatment (178 papers), Bipolar Disorder and Treatment (73 papers) and Treatment of Major Depression (59 papers). John M. Davis is often cited by papers focused on Schizophrenia research and treatment (178 papers), Bipolar Disorder and Treatment (73 papers) and Treatment of Major Depression (59 papers). John M. Davis collaborates with scholars based in United States, Germany and United Kingdom. John M. Davis's co-authors include Stefan Leucht, Werner Kissling, Rolf R. Engel, Myrto Samara, Stephan Heres, Nancy Chen, Joseph R. Hibbeln, Georgia Salanti, Ghanshyam N. Pandey and E. Angela Murphy and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

John M. Davis

599 papers receiving 35.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

2013 1.8k citations Stefan Leucht, Myrto Samara et al. profile →
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

2008 1.4k citations Stefan Leucht, John M. Davis et al. profile →
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis

2019 963 citations Johannes Schneider‐Thoma, Myrto Samara et al. profile →
Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study

2007 731 citations Joseph R. Hibbeln, John M. Davis et al. profile →
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics

2003 706 citations John M. Davis et al. profile →
The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis

1997 630 citations John M. Davis et al. profile →
The Altman Self-Rating Mania Scale

1997 621 citations John M. Davis et al. profile →
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

2012 594 citations Stefan Leucht, Stephan Heres et al. profile →
A decrease of reelin expression as a putative vulnerability factor in schizophrenia

1998 584 citations John M. Davis et al. profile →
Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry

2006 531 citations Joseph R. Hibbeln, John M. Davis et al. profile →
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis

2010 513 citations Werner Kissling, John M. Davis et al. profile →
Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.

2016 485 citations Stefan Leucht, Myrto Samara et al. Schizophrenia Bulletin profile →
Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis

2013 379 citations Christopher E. Ramsden, Daisy Zamora et al. profile →
Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors

2017 350 citations Stefan Leucht, Myrto Samara et al. profile →
Guidelines for the use of cell lines in biomedical research

2014 318 citations John M. Davis et al. profile →
Is Oxytocin “Nature’s Medicine”?

2020 260 citations John M. Davis et al. profile →

Peers

Countries citing papers authored by John M. Davis

Since Specialization

Citations

This map shows the geographic impact of John M. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Davis more than expected).

Fields of papers citing papers by John M. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Davis. The network helps show where John M. Davis may publish in the future.

Co-authorship network of co-authors of John M. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Davis. A scholar is included among the top collaborators of John M. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Davis. John M. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Formal and functional factors in classifier choice: Evidence from American Sign Language and Danish Sign Language 2025 ·Open Linguistics ·Elisabeth Engberg-Pedersen, Diane Brentari, John M. Davis	1
2	Peripheral Blood Mononuclear Cell Expression of Cation-Chloride Cotransporter (CCC) Genes in Premenstrual Dysphoric Disorder (PMDD) across the Menstrual Cycle—A Preliminary Study 2024 ·Biology ·Soojeong Cho, (unknown), Sunni L. Mumford, (unknown), (unknown), John M. Davis, Ajna Hamidovic	1
3	Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials 2023 ·Schizophrenia Bulletin ·Dongfang Wang, Johannes Schneider‐Thoma, Spyridon Siafis, (unknown), (unknown), Hui Wu, Yikang Zhu, John M. Davis, Josef Priller, Stefan Leucht	12
4	A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder 2023 ·European Neuropsychopharmacology ·Mark Weiser, Linda Levi, Jin‐Young Park, (unknown), Valentin Matei, Michael H. Davidson, (unknown), Israel Dudkiewicz, John M. Davis	5
5	Endogenous Derivatives of Linoleic Acid and their Stable Analogs Are Potential Pain Mediators 2022 ·SHILAP Revista de lepidopterología ·(unknown), Anthony F. Domenichiello, (unknown), Gregory S. Keyes, (unknown), John M. Davis, Christopher E. Ramsden, Santosh K. Mishra	6
6	A 52‐week prophylactic randomised control trial of omega‐3 polyunsaturated fatty acids in bipolar disorder 2020 ·Bipolar Disorders ·Genevieve McPhilemy, (unknown), (unknown), Joseph R. Hibbeln, John M. Davis, Colm McDonald, Brian Hallahan	13
7	A systems approach for discovering linoleic acid derivatives that potentially mediate pain and itch 2017 ·Science Signaling ·Christopher E. Ramsden, Anthony F. Domenichiello, Zhi‐Xin Yuan, Matthew R. Sapio, Gregory S. Keyes, Santosh K. Mishra, (unknown), Sharon F. Majchrzak‐Hong, Daisy Zamora, Mark S. Horowitz, John M. Davis, Alexander V. Sorokin, (unknown), (unknown), (unknown), Michael R. Vasko, Nehal N. Mehta, Andrew J. Mannes, Michael J. Iadarola	60
8	Fall from heights: does height really matter? 2017 ·European Journal of Trauma and Emergency Surgery ·(unknown), Jason D. Sciarretta, (unknown), (unknown), Andrea Romano, John M. Davis, Antonio Pepe	28
9	Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1. breakdown → 2016 ·Schizophrenia Bulletin ·Stefan Leucht, Myrto Samara, Stephan Heres, John M. Davis	485
10	Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses 2012 ·The British Journal of Psychiatry ·Stefan Leucht, (unknown), Werner Kissling, Markus Dold, John M. Davis	230
11	It Can Be Taught: Explorations into Teaching the Foundations for Multicultural Effectiveness 2011 ·Language arts journal of Michigan ·Randall E. Osborne, (unknown), John M. Davis	4
12	Lithium-Induced Renal Insufficiency 2011 ·Journal of Clinical Psychopharmacology ·David S. Janowsky, (unknown), Qiaoyan Hu, John M. Davis	5
13	Feasibility of Reducing the Duration of Placebo-Controlled Trials in Schizophrenia Research 2008 ·Schizophrenia Bulletin ·Robert P. McMahon, Deanna L. Kelly, Douglas L. Boggs, Lan Li, Qiaoyan Hu, John M. Davis, William T. Carpenter	23
14	Carl Ludwig's revolutionary concept of renal function 1994 ·John M. Davis	2
15	Mania: Sympathoadrenal function and clinical state 1991 ·Psychiatry Research ·Alan C. Swann, Steven K. Secunda, Stephen H. Koslow, (unknown), Charles L. Bowden, James W. Maas, John M. Davis, Eli Robins	16
16	Suicidal youth : school-based intervention and prevention 1991 ·Jossey-Bass eBooks ·John M. Davis, Jonathan Sandoval	13
17	Psychiatry : diagnosis & therapy 1988 ·Prentice Hall eBooks ·Joseph A. Flaherty, (unknown), John M. Davis	4
18	The Affective disorders 1983 ·John M. Davis, James W. Maas	61
19	Plasma butaperazine levels in long-term chronic non-responding schizophrenics. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Robert C. Smith, H. Dekirmenjian, John M. Davis, John W. Crayton, (unknown)	4
20	DAR volume 43 issue 3 Cover and Front matter 1976 ·Journal of Dairy Research ·Pete Thomas, Michael E. Kelly, Hans Peeters, Stephen Mepham, John M. Davis, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact